Literature DB >> 6854380

Regional blood-to-tissue transport in RT-9 brain tumors.

P Molnar, R G Blasberg, M Horowitz, B Smith, J Fenstermacher.   

Abstract

Regional blood-to-tissue transport, expressed as a unidirectional transfer rate constant (K), was measured in experimental RT-9 brain tumors using 14C-alpha-aminoisobutyric acid (AIB) and quantitative autoradiographic techniques. The magnitude of K depends on the permeability, surface area, and blood flow of the tissue capillaries. The transfer rate constant was variable within tumor tissue (range 0.001 to 0.178 ml/gm/min) and depended on tumor size, location (intraparenchymal, meningeal, or choroid plexus associated), and to a lesser extent on necrosis and cyst formation. Brain adjacent to tumor had higher K values, particularly around larger tumors (0.004 to 0.014 ml/gm/min), than corresponding brain regions in the contralateral hemisphere (0.001 to 0.002 ml/gm/min). Estimates of the fractional extraction of AIB by intraparenchymal tumors were between 0.008 and 0.4 ml/gm/min. Values of fractional extraction in this range indicate that tumor capillaries are not freely permeable to this solute. The values of K measured with AIB in this study, for the most part, approximate the permeability-surface area product of tumor and brain capillaries. The experimental data suggest that the permeability-surface area characteristics of the microvasculature in small RT-9 tumors are similar to those of the host tissue, whereas the microvasculature of larger RT-9 tumors is influenced more by intrinsic tumor factors.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6854380     DOI: 10.3171/jns.1983.58.6.0874

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  12 in total

1.  [Blood-brain barrier and the penetration of cytostatic drugs].

Authors:  C Unger; H Eibl; H W von Heyden; B Krisch; G A Nagel
Journal:  Klin Wochenschr       Date:  1985-06-18

Review 2.  Transport of molecules across tumor vasculature.

Authors:  R K Jain
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

3.  Increased capillary permeability in rat brain induced by factors secreted by cultured C6 glioma cells: role in peritumoral brain edema.

Authors:  T Ohnishi; P B Sher; J B Posner; W R Shapiro
Journal:  J Neurooncol       Date:  1991-02       Impact factor: 4.130

4.  Murine sarcoma virus-induced brain tumors. Concurrent measurements of blood flow and transcapillary transport.

Authors:  F J Vriesendorp; D R Groothuis; N A Vick
Journal:  J Neurooncol       Date:  1984       Impact factor: 4.130

5.  Growth of 9-L and RT-9 gliosarcoma in female rats.

Authors:  T Furuta; H A Wilkinson; T Fujiwara
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

6.  Local blood-to-tissue transport in Walker 256 metastatic brain tumors.

Authors:  R G Blasberg; W R Shapiro; P Molnar; C S Patlak; J D Fenstermacher
Journal:  J Neurooncol       Date:  1984       Impact factor: 4.130

7.  MRI measurement of change in vascular parameters in the 9L rat cerebral tumor after dexamethasone administration.

Authors:  James R Ewing; Stephen L Brown; Tavarekere N Nagaraja; Hassan Bagher-Ebadian; Ramesh Paudyal; Swayamprava Panda; Robert A Knight; Guangliang Ding; Quan Jiang; Mei Lu; Joseph D Fenstermacher
Journal:  J Magn Reson Imaging       Date:  2008-06       Impact factor: 4.813

Review 8.  Blood flow and blood-to-tissue transport in 9L gliosarcomas: the role of the brain tumor model in drug delivery research.

Authors:  R D Fross; P C Warnke; D R Groothuis
Journal:  J Neurooncol       Date:  1991-12       Impact factor: 4.130

9.  Physiologic upper limit of pore size in the blood-tumor barrier of malignant solid tumors.

Authors:  Hemant Sarin; Ariel S Kanevsky; Haitao Wu; Alioscka A Sousa; Colin M Wilson; Maria A Aronova; Gary L Griffiths; Richard D Leapman; Howard Q Vo
Journal:  J Transl Med       Date:  2009-06-23       Impact factor: 5.531

Review 10.  Recent progress towards development of effective systemic chemotherapy for the treatment of malignant brain tumors.

Authors:  Hemant Sarin
Journal:  J Transl Med       Date:  2009-09-01       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.